Tyrothricin
Also known as: Gramicidin/Tyrocidine mixture, Lemocin, Throatin, Tyrocidine/Gramicidin mixture, Tyrosur, Tyrothricin, Tyrothricin ointment
Source Tyrothricin at Peptiology
Save 10% with code PEPTI-BOSSRABBIT-10
Affiliate link: we earn a commission on purchases made through this link, at no extra cost to you.
Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.
Summary
Tyrothricin is a topical and oromucosal antimicrobial peptide mixture containing gramicidin and tyrocidine. It is sold over‑the‑counter for superficial skin lesions, infected wounds and, in some formulations, sore‑throat relief. The preparation exploits broad‑spectrum activity against bacteria, fungi and certain viruses, and is marketed as a low‑resistance alternative to conventional antibiotics.
Mechanism of Action
Tyrothricin consists of cationic cyclic peptides that interact with microbial membranes. Gramicidin inserts into lipid bilayers forming ion‑conducting channels, while tyrocidine disrupts membrane integrity through amphiphilic insertion. These actions lead to rapid loss of membrane potential and cell lysis, giving the mixture bactericidal, fungicidal and some antiviral effects. Because the target is the physical membrane rather than specific proteins, resistance development in vitro is rare.
What the Research Shows
Clinical evidence for tyrothricin is limited but encouraging. A double‑blind, multicenter trial (n=131) showed that a 0.1 % powder applied twice daily accelerated healing of infected or at‑risk cutaneous lesions compared with placebo (greater daily radius reduction and wound‑index improvement). In a split‑face acne study (n=24), 0.1 % topical tyrothricin reduced inflammatory and non‑inflammatory lesions and was better tolerated than clindamycin + benzoyl peroxide or benzoyl peroxide alone. Systematic review of topical antibiotics for sore throat found sparse, low‑quality data, preventing conclusions about efficacy or safety. Reviews highlight tyrothricin’s broad antimicrobial spectrum, low resistance potential, and historical use on mucous membranes and wounds.
Reported Benefits
Randomised data demonstrate faster wound closure and improved wound‑index scores versus placebo in superficial skin lesions. In acne, tyrothricin reduced lesion counts and caused fewer product‑related adverse events than standard topical regimens. The peptide mixture offers broad‑spectrum activity without documented resistance development, and systemic absorption appears negligible, supporting its use for localized infections.
Limitations of the Evidence
Evidence is confined to small, short‑term trials focused on skin applications; no large‑scale comparative studies with modern antibiotics exist. Data on oromucosal use for sore throat are lacking, and systematic reviews label the evidence as sparse and of poor quality. Long‑term safety, effects on diverse bacterial species, and efficacy in deeper or systemic infections remain untested.
Safety Considerations
Topical tyrothricin was generally well tolerated. In the wound‑healing trial, adverse events occurred equally in tyrothricin and placebo groups, with no clear drug‑related pattern. The acne trial reported fewer local irritant reactions than benzoyl peroxide‑based comparators. Reviews note minimal systemic exposure, but local irritation or hypersensitivity may occur. Evidence for safety in oromucosal use is limited, and routine monitoring is advisable for individuals with known peptide allergies.
How It Is Administered
Tyrothricin is supplied as a topical powder or cream (typically 0.1 % w/w) applied to the affected skin area, usually twice daily for several days. Oromucosal formulations (e.g., lozenges) are intended for local throat application. The product is not intended for systemic use, and dosing instructions are provided on the packaging.
Routes of Administration
Goals & Uses
- Treatment of sore throat and oral infectionsAntimicrobial / Local ENTModerate
- Topical skin infection treatmentDermatology / AntimicrobialModerate
- Oral cavity antisepsisDental / AntimicrobialLow
- treat superficial skin infectionsAntibacterialModerate
Contraindications
- Known hypersensitivity to tyrothricin or its componentsAllergyHigh
- Application to large open wounds or deep woundsWound TypeModerate
- Systemic administrationRoute Of AdministrationHigh
- hypersensitivity to tyrothricin or componentsAllergyHigh
Adverse Effects
- Local skin irritationDermatologicalCommon
- Contact dermatitisDermatologicalUncommon
- Local irritation or burning sensationLocal ReactionUncommon
- NauseaGastrointestinalUncommonFeeling of sickness or urge to vomit
- HemolysisHematologicRare
- Allergic contact dermatitisImmunologicalRare
Drug Interactions
- Other topical antibioticsLow
- systemic antibioticsLow
Population Constraints
- PregnancyReproductive SafetyRelative
- Infants <2 monthsAgeRelative
- Patients with known hemolytic disordersHematologicalRelative
- Infants and neonatesPediatricRelative
Regulatory Status
- European UnionApprovedApproved: topical treatment of skin infectionsavailable as prescription ointment
- United StatesUnapprovednot FDA‑approved as a drug product
- United KingdomApprovedApproved: Topical/oromucosal antibacterial useAvailable in OTC throat lozenge formulations in the UK.
Approved in several European countries as an over-the-counter topical antiseptic and throat lozenge ingredient. Not systemically administered due to hemolytic toxicity. Available in Germany and other EU countries as lozenges (e.g., Tyrosur, Lemocin). Not formally approved by the FDA for any indication in the United States.
Evidence & Sources
- Journal ArticleModerateBayerl C, Völp A2004-01-01T00:00:00.000000Z
- Journal ArticleModerateRichter C, et al.2016-01-01T00:00:00.000000Z
- Journal ArticleHighEssack S, et al.2019-01-01T00:00:00.000000Z
- Journal ArticleModerateKorting HC, et al.2012-01-01T00:00:00.000000Z
- Journal ArticleModerateLang C, Staiger C2016-01-01T00:00:00.000000Z
- Journal ArticleModerateKanof NB1970-01-01T00:00:00.000000Z
Frequently Asked Questions
What types of infections can tyrothricin treat?
It is approved for superficial bacterial, fungal or mixed‑microbe skin infections and for minor wounds. Some formulations are marketed for sore‑throat relief, but robust clinical data for that use are lacking.
Does tyrothricin cause antibiotic resistance?
Current studies and reviews report that, unlike many conventional antibiotics, tyrothricin’s membrane‑disrupting action does not readily select for resistant strains in vitro.
Is tyrothricin safe to use on large skin areas?
Clinical trials have shown good local tolerability with no systemic effects when applied to small‑area wounds. Safety on extensive body surfaces has not been specifically studied.
Can I use tyrothricin instead of oral antibiotics for a sore throat?
Evidence for efficacy in sore‑throat treatment is sparse and of low quality. Health‑care guidance currently discourages routine use of topical antibiotics for viral or self‑limiting throat infections.
What should I do if I develop irritation after applying tyrothricin?
Stop the product and wash the area with water. If irritation persists or worsens, seek medical advice, especially if you have a known allergy to peptide antibiotics.
What is Tyrothricin?
Tyrothricin is a topical and oromucosal antimicrobial peptide mixture containing gramicidin and tyrocidine. It is sold over‑the‑counter for superficial skin lesions, infected wounds and, in some formulations, sore‑throat relief. The preparation exploits broad‑spectrum activity against bacteria, fungi and certain viruses, and is marketed as a low‑resistance alternative to conventional antibiotics.
What is Tyrothricin used for?
Tyrothricin is educationally associated with: Treatment of sore throat and oral infections, Topical skin infection treatment, Oral cavity antisepsis, treat superficial skin infections. Educational only — not medical advice.
How is Tyrothricin administered?
Recorded routes of administration: Oromucosal, Topical.
What are the potential side effects of Tyrothricin?
Reported adverse effects include: Local skin irritation, Contact dermatitis, Local irritation or burning sensation, Nausea, Hemolysis, Allergic contact dermatitis. This list is not exhaustive — consult a qualified clinician.
Who should avoid Tyrothricin?
Recorded contraindications: Known hypersensitivity to tyrothricin or its components, Application to large open wounds or deep wounds, Systemic administration, hypersensitivity to tyrothricin or components. Consult a qualified clinician before use.